Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
see.ip - Details for VERWENDUNG VON ZELLDURCHLÄSSIGEN PEPTIDHEMMERN DES JNK-SIGNALTRANSDUKTIONSWEGES ZUR BEHANDLUNG VERSCHIEDENER KRANKHEITEN
Details for 2015000994
Up to date per 11.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2015000994
Title / Product Name
VERWENDUNG VON ZELLDURCHLÄSSIGEN PEPTIDHEMMERN DES JNK-SIGNALTRANSDUKTIONSWEGES ZUR BEHANDLUNG VERSCHIEDENER KRANKHEITEN
Status
Deleted
Protection Type
European Patent
(AT-) Application Number
2015000994
EP Publication Number
2985031
E-Number
883180
Language
EN
PCT Number
-
Publication Date
17.02.2016 A
12.04.2017 B1
Registration Date
12.04.2017
AT Publication Date
15.05.2017
Application Date
02.06.2009
Registration Number
-
Priorities
30.05.2008
WO
PCT/EP2008/004341
IPC
A61K 38/01 20060101AFI20151117BHEP
Maximum Duration of Protection
02.06.2029
Owner
Xigen Inflammation Ltd.
Arch. Makariou III 195 Neocleous House
3030 Limassol
CY
Representative
No representatives present
Inventor
Bonny, Christophe
En vernaules
1580 Avenches
CH